BBVA
PFE icon

Banco Bilbao Vizcaya Argentaria’s Pfizer PFE Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.4M Buy
1,178,232
+1,117
+0.1% +$29.2K 0.18% 100
2026
Q1 		$33M Sell
1,177,115
-26,235
-2% -$698K 0.23% 70
2025
Q4 		$30M Sell
1,203,350
-564,462
-32% -$14.2M 0.21% 77
2025
Q3 		$44.9M Buy
1,767,812
+30,478
+2% +$752K 0.34% 53
2025
Q2 		$42.1M Buy
1,737,334
+26,995
+2% +$630K 0.38% 45
2025
Q1 		$43.3M Buy
1,710,339
+456,583
+36% +$11.9M 0.44% 43
2024
Q4 		$33.4M Buy
1,253,756
+305,889
+32% +$8.3M 0.35% 56
2024
Q3 		$27.4M Sell
947,867
-17,078
-2% -$498K 0.27% 76
2024
Q2 		$27M Sell
964,945
-324,288
-25% -$8.93M 0.28% 74
2024
Q1 		$35.7M Buy
1,289,233
+28,484
+2% +$790K 0.41% 47
2023
Q4 		$36.2M Buy
1,260,749
+156,456
+14% +$4.73M 0.43% 49
2023
Q3 		$36.2M Buy
1,104,293
+319,915
+41% +$11.3M 0.49% 44
2023
Q2 		$28.7M Sell
784,378
-387,901
-33% -$15.1M 0.37% 62
2023
Q1 		$47.8M Buy
1,172,279
+133,106
+13% +$5.75M 0.59% 31
2022
Q4 		$53.2M Sell
1,039,173
-91,736
-8% -$4.4M 0.78% 21
2022
Q3 		$49.6M Buy
1,130,909
+77,346
+7% +$3.76M 0.8% 18
2022
Q2 		$55.2M Buy
1,053,563
+172,957
+20% +$8.81M 0.83% 19
2022
Q1 		$45.3M Buy
880,606
+250,776
+40% +$13M 0.61% 31
2021
Q4 		$38.3M Buy
629,830
+299,940
+91% +$14.9M 0.51% 34
2021
Q3 		$14.5M Buy
329,890
+25,071
+8% +$1.11M 0.23% 80
2021
Q2 		$12M Sell
304,819
-15,237
-5% -$593K 0.21% 89
2021
Q1 		$11.4M Sell
320,056
-238,068
-43% -$8.45M 0.23% 87
2020
Q4 		$20.5M Buy
558,124
+144,416
+35% +$5.3M 0.48% 39
2020
Q3 		$14.4M Buy
413,708
+58,927
+17% +$2.07M 0.42% 42
2020
Q2 		$11M Buy
354,781
+130,927
+58% +$4.45M 0.35% 54
2020
Q1 		$6.93M Buy
223,854
+46,952
+27% +$1.6M 0.25% 81
2019
Q4 		$6.58M Buy
+176,902
New +$6.3M 0.21% 95

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's PFE Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria increased its Pfizer (PFE) stake by 0.09% in Q2 2026, buying an estimated $29.2K and bringing the position to 1,178,232 shares worth $28.4M. The position accounts for 0.18% of the portfolio, ranked #100.

Banco Bilbao Vizcaya Argentaria first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $55.2M in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 1,178,232 shares of Pfizer worth $28.4M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria bought 1,117 Pfizer shares in Q2 2026, an estimated $29.2K.
  • Pfizer made up 0.18% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #100 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Pfizer position peaked at $55.2M in Q2 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.